Clinical Trial Update: Curosurf/Budesonide for Infants With Respiratory Distress Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluating the combination of Curosurf (poractant alfa) and budesonide for neonatal respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress Syndrome

Drugs mentioned

• Budesonide (BUDESONIDE)
• Curosurf (poractant alfa)

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Respiratory Distress Syndrome | NA | Status: COMPLETED